Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.

Océane Landon-Cardinal,Diane Friedman,Marguerite Guiguet,Pascal Laforêt,Nicholas Heming,Emmanuelle Salort-Campana,Fabienne Jouen,Yves Allenbach,Olivier Boyer,Lucienne Chatenoud,Bruno Eymard,Tarek Sharshar,Olivier Benveniste

Journal of neuromuscular diseases（2018）

引用 32|浏览36

暂无评分

摘要

These results provide data on the effect of RTX in patients with severe, refractory anti-AChR Abs generalized MG. Even though primary outcome was only reached in a single patient at M12, a beneficial effect of RTX on muscle function was seen in half of the patients at M12 and persisted in a third of patients at M18.

查看译文

关键词

Myasthenia gravis,anti-AchR,anti-CD20 monoclonal antibodies,anti-acetylcholine receptor antibodies,refractory generalized myasthenia,rituximab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要